BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2018 7:56:07 AM | Browse: 984 | Download: 1190
Publication Name World Journal of Gastroenterology
Manuscript ID 37513
Country/Territory Israel
2018-01-03 21:08
Peer-Review Started
2018-01-04 06:08
To Make the First Decision
2018-01-17 01:41
Return for Revision
2018-01-18 02:35
2018-03-10 12:43
Second Decision
2018-03-22 08:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-03-25 16:38
Articles in Press
2018-03-25 16:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-04-18 06:04
Publish the Manuscript Online
2018-04-19 07:56
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Manuscript Source Unsolicited Manuscript
All Author List Yossi Ventura, Brian I Carr, Issac Kori, Vito Guerra and Oren Shibolet
Author(s) ORCID Number
Yossi Ventura http://orcid.org/0000-0003-2975-8627
Brian I Carr http://orcid.org/0000-0002-6111-5077
Issac Kori http://orcid.org/0000-0002-9716-4719
Vito Guerra http://orcid.org/0000-0001-7827-1909
Oren Shibolet http://orcid.org/0000-0003-6111-5067
Funding Agency and Grant Number
Corresponding Author Oren Shibolet, FRCP (C), MD, PhD, Academic Research, Chief Doctor, Professor, Senior Lecturer, Department of Gastroenterology and Liver Disease, Tel-Aviv Medical Center and the Sackler Faculty of Medicine, Shibolet, O (reprint author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, Liver Unit, IL-69978 Tel Aviv, Israel., Tel-Aviv University, Liver Unit, Department of Gastroenterology and Liver Disease, Tel-Aviv Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. weizman 6 orensh@tlvmc.gov.il., Tel aviv 6423906, Israel. orensh@tlvmc.gov.il
Key Words Hepatocellular carcinoma; Aggressiveness index; Liver function; Transarterial chemoembolization; Survival
Core Tip Our cohort’s population included patients with multiple underlying liver diseases and can be widely generalized. The aggressiveness index (AgI) was correlated with survival. AgI > 4 was associated with decreased survival. Combining the AgI with elevated GGTP and ALKP levels improved its prognostic yield in our patient population. We validated the AgI as a prognostic tool to predict overall survival in a novel population of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Publish Date 2018-04-19 07:56
Citation Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649
URL http://www.wjgnet.com/1007-9327/full/v24/i15/1641.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i15.1641
Full Article (PDF) WJG-24-1641.pdf
Full Article (Word) WJG-24-1641.doc
Manuscript File 37513-Review.docx
Answering Reviewers 37513-Answering reviewers.pdf
Audio Core Tip 37513-Audio core tip.m4a
Biostatistics Review Certificate 37513-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 37513-Conflict-of-interest statement.pdf
Copyright License Agreement 37513-Copyright assignment.pdf
Institutional Review Board Approval Form or Document 37513-Institutional review board statement.pdf
Peer-review Report 37513-Peer-review(s).pdf
Scientific Misconduct Check 37513-Scientific misconduct check.pdf
Scientific Editor Work List 37513-Scientific editor work list.pdf